Two receptors. Smaller dose. Easier to start.
A dual-agonist formulation at a lower prescribed dose, targeting both GLP-1 and GIP pathways.
1–2.5mg
Weekly dose range
Lower-dose compounded GLP-1 weight care, reviewed by a licensed provider and fulfilled through a state-licensed compounding pharmacy.
Active Ingredient
Tirzepatide
GLP-1 + GIP dual agonist
Dosage
Once weekly
Provider-titrated · low dose
Form
Subcutaneous
Multi-dose vial + syringe
Source
503A pharmacy
Compounded per your prescription · U.S. licensed

$115/mo, flat rate
availableCompounded Tirzepatide is a medication prepared by a state-licensed pharmacy pursuant to a valid prescription from a licensed clinician. Compounded drugs are not FDA-approved as a finished product, though their active ingredients may be FDA-approved. Prescription eligibility is determined by a licensed clinician after intake review.
Lower-dose compounded GLP-1 weight care, reviewed by a licensed provider and fulfilled through a state-licensed compounding pharmacy.
Active Ingredient
Tirzepatide
GLP-1 + GIP dual agonist
Dosage
Once weekly
Provider-titrated · low dose
Form
Subcutaneous
Multi-dose vial + syringe
Source
503A pharmacy
Compounded per your prescription · U.S. licensed

$115/mo, flat rate
availableCompounded Tirzepatide is a medication prepared by a state-licensed pharmacy pursuant to a valid prescription from a licensed clinician. Compounded drugs are not FDA-approved as a finished product, though their active ingredients may be FDA-approved. Prescription eligibility is determined by a licensed clinician after intake review.
A dual-agonist formulation at a lower prescribed dose, targeting both GLP-1 and GIP pathways.
1–2.5mg
Weekly dose range
Long-term balance and maintenance, not aggressive weight loss.
U.S.-licensed clinicians on every prescription, no auto-approvals.
Less nausea, less GI disruption than full-dose protocols.
Temperature-controlled delivery, included in your monthly cost.
A dual-agonist formulation at a lower prescribed dose, targeting both GLP-1 and GIP pathways.
1–2.5mg
Weekly dose range
Long-term balance and maintenance, not aggressive weight loss.
U.S.-licensed clinicians on every prescription, no auto-approvals.
Less nausea, less GI disruption than full-dose protocols.
Temperature-controlled delivery, included in your monthly cost.
A dual-agonist formulation at a lower prescribed dose, targeting both GLP-1 and GIP pathways.
1–2.5mg
Weekly dose range
Long-term balance and maintenance, not aggressive weight loss.
U.S.-licensed clinicians on every prescription, no auto-approvals.
Some patients on microdose protocols report tolerability benefits. Your clinician will help determine what's appropriate for you.
Temperature-controlled delivery, included in your monthly cost.
Step 1 • Assessment
Tell us about your health history and goals. Takes about 2 minutes.
Step 2 • Provider Review
A licensed provider reviews your intake and determines next steps
Dr. Walsh
Week 4 check-in, how are you feeling?
Down 6 lbs and energy is up.
Step 3 • Ongoing Care
Your provider stays one message away for support, questions, and refills.
Quick online assessment • Private
The dual-action science
Same GLP-1 and GIP pathways as standard tirzepatide. Lower dose, fewer side effects, and easier to stay on. A protocol based on your health history, reviewed by licensed clinicians.
Activates the GLP-1 pathway
Mimics the GLP-1 hormone to reduce hunger signals in the brain, helping you feel satisfied with less food — without shutting down appetite entirely.
Supports metabolic function
Improves blood sugar response and insulin sensitivity over time. Works with your body's existing systems, not against them.
A protocol you can stay on
Lower doses mean smoother titration and less nausea. The goal is long-term balance — not aggressive short-term loss that's hard to maintain.
Starting low and increasing over time helps your body adjust and reduces side effects. Your provider reviews your response at each stage.Starting low and increasing over time gives your body time to adjust. Your provider reviews your response at each stage.
Weeks 1–4
1mg
Starting microdose. Minimal side effects. Your body begins adapting to GLP-1 and GIP signaling at the lowest possible level.The starter dose. A low starting point gives your body time to adjust to dual GLP-1/GIP activity at a microdose level.
Once weekly · subcutaneous
Weeks 5–8
1.5mg
Dose increases as your body adapts. Many patients begin noticing reduced appetite and improved energy at this stage.Many patients notice early changes in appetite and energy at this stage.
Once weekly · subcutaneous
Weeks 9–12
2mg
A gradual step up for patients tolerating the previous dose well.A gradual step up for patients tolerating the previous dose well.
Once weekly · subcutaneous
Weeks 13+
2.5mg
The microdose maintenance level. Your provider may keep you here or discuss a standard full-dose plan.The microdose maintenance level. Your provider may keep you here or discuss transitioning to a standard full-dose plan based on your response.
Once weekly · subcutaneous
Dose schedules are determined by your provider based on your individual response. Results vary. Individual results are not guaranteed.Doses are prescribed and reviewed by a licensed provider. Your actual titration schedule may vary based on your health history and response to treatment.
GLP-1 microdosing uses lower-than-standard doses of a compounded GLP-1 medication, prepared by a state-licensed pharmacy against a valid prescription, for a gentler start with fewer side effects.
They act on the same GLP-1 and GIP receptors that help regulate appetite and blood sugar as standard doses, just at a lower level so your body can adjust gradually.
It uses the same active ingredient and clinician review, but at lower doses — which can mean smoother titration and fewer side effects like nausea.
Many patients see results on lower doses, though individual outcomes vary. Your provider helps find the dose that fits your goals and tolerance.
Your provider reviews your progress and adjusts your plan — some patients stay at a low dose, others step up or transition to a maintenance plan.
Tirzepatide has an established clinical safety record as the active ingredient in FDA-approved Mounjaro and Zepbound. Your compounded medication is prepared at a state-licensed, CGMP-compliant pharmacy and reviewed by a licensed U.S. provider. As with any medication, side effects are possible — your provider monitors your response throughout treatment.
Once your prescription is approved, medication ships directly to your door in temperature-controlled packaging, typically within a few business days.
Still have questions? Contact us
Ready to start?
Share your health history online in about 90 seconds. A licensed provider reviews your intake and prescribes if appropriate.
Takes 90 seconds · Private · Always free
